公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study | Satoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH | Journal of Clinical Oncology | 528 | 467 | |
2016 | A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects | Lai W.-Y.; Huang B.-T.; Wang J.-W.; Lin P.-Y.; PAN-CHYR YANG | Molecular Therapy - Nucleic Acids | 95 | 86 | |
2019 | A novel TNF-α-targeting aptamer for TNF-α-mediated acute lung injury and acute liver failure | Lai W.-Y.; Wang J.-W.; Huang B.-T.; Lin E.P.-Y.; PAN-CHYR YANG | Theranostics | 87 | 76 | |
2010 | Prognostic implication of MET overexpression in myxofibrosarcomas: An integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis | JEN-CHIEH LEE ; Li C.-F.; Fang F.-M.; Wang J.-W.; YUNG-MING JENG ; Yu S.C.; Lin Y.-T.; Wu J.-M.; Tsai J.-W.; Li S.-H.; Huang H.-Y. | Modern Pathology | 29 | 25 |